4-1BB/EpCAM XFab (Immunoah)

N/A

Report date: 2024/07/31 11:36:37

Base Information

Drug Name4-1BB/EpCAM XFab (Immunoah)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionTumor necrosis factor receptor superfamily member 9 agonistsAnti-EpCAM

TargetsTumor necrosis factor receptor superfamily member 9Epithelial cell adhesion molecule

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesBeijng Immunoah Pharma Tech Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesBeijng Immunoah Pharma Tech Co Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A